Total Payments
$1,086
2022 Payments
$405.04
Companies
12
Transactions
57

Payment Breakdown by Category

Food & Beverage$1,086 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,086 57 100.0%

Top Paying Companies

Company Total Records Latest Year
E.R. Squibb & Sons, L.L.C. $225.51 15 $0 (2022)
Gilead Sciences, Inc. $163.95 8 $0 (2022)
PFIZER INC. $146.57 10 $0 (2022)
Alexion Pharmaceuticals, Inc. $121.11 4 $0 (2021)
ABBVIE INC. $116.93 2 $0 (2022)
AstraZeneca Pharmaceuticals LP $111.76 6 $0 (2022)
Boehringer Ingelheim Pharmaceuticals, Inc. $60.08 4 $0 (2022)
Bayer HealthCare Pharmaceuticals Inc. $40.00 2 $0 (2022)
Incyte Corporation $37.21 2 $0 (2022)
Karyopharm Therapeutics Inc. $31.91 2 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2022 $405.04 25 E.R. Squibb & Sons, L.L.C. ($116.70)
2021 $308.21 16 E.R. Squibb & Sons, L.L.C. ($92.63)
2020 $325.38 14 AbbVie Inc. ($87.50)
2019 $47.10 2 Alexion Pharmaceuticals, Inc. ($47.10)

All Payment Transactions

57 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
12/08/2022 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $15.02 General
Category: Cardiovascular
10/28/2022 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $6.71 General
Category: Cardiovascular
10/28/2022 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $5.59 General
Category: Cardiovascular
09/14/2022 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $10.49 General
Category: Oncology
09/08/2022 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $15.52 General
Category: Cardiovascular
08/10/2022 Foundation Medicine, Inc. FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX Food and Beverage In-kind items and services $17.74 General
Category: ONCOLOGY
07/06/2022 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $15.15 General
Category: Cardiovascular
06/14/2022 PFIZER INC. ELIQUIS (Drug), PAXLOVID Food and Beverage In-kind items and services $13.62 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
06/07/2022 AstraZeneca Pharmaceuticals LP BRILINTA (Drug) Food and Beverage In-kind items and services $22.87 General
Category: Cardiovascular and Metabolism
06/06/2022 Bayer HealthCare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $20.00 General
Category: Cardio-renal
06/03/2022 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $15.72 General
Category: Cardiovascular
05/24/2022 Gilead Sciences, Inc. Food and Beverage In-kind items and services $17.89 General
04/22/2022 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $13.41 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
04/19/2022 Karyopharm Therapeutics Inc. XPOVIO (Drug) Food and Beverage In-kind items and services $17.06 General
Category: Oncology
04/12/2022 Gilead Sciences, Inc. Food and Beverage In-kind items and services $17.21 General
04/08/2022 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $18.17 General
Category: DIABETES
04/01/2022 Incyte Corporation JAKAFI (Drug), PEMAZYRE Food and Beverage Cash or cash equivalent $17.95 General
Category: Hematology/Oncology
04/01/2022 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $13.89 General
03/28/2022 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $12.24 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
03/16/2022 Karyopharm Therapeutics Inc. XPOVIO (Drug) Food and Beverage In-kind items and services $14.85 General
Category: Oncology
03/10/2022 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $18.61 General
Category: Cardiovascular
03/08/2022 Gilead Sciences, Inc. Food and Beverage In-kind items and services $18.89 General
03/07/2022 Bayer HealthCare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $20.00 General
Category: Cardio-renal
02/24/2022 ABBVIE INC. AVYCAZ (Drug) Food and Beverage In-kind items and services $29.43 General
Category: ANTI-INFECTIVE
02/14/2022 Gilead Sciences, Inc. Food and Beverage In-kind items and services $17.01 General

About Dr. Pawina Subedi, MD

Dr. Pawina Subedi, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Waterloo, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/23/2019. The National Provider Identifier (NPI) number assigned to this provider is 1184277642.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pawina Subedi, MD has received a total of $1,086 in payments from pharmaceutical and medical device companies, with $405.04 received in 2022. These payments were reported across 57 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,086).

Practice Information

Products in Payments

  • ELIQUIS (Drug) $146.13
  • Ultomiris (Drug) $98.39
  • CAMZYOS (Drug) $73.71
  • XELJANZ (Drug) $65.58
  • BRILINTA (Drug) $62.07
  • OPDIVO (Biological) $47.42
  • Kerendia (Drug) $40.00
  • JAKAFI (Drug) $37.21
  • LOKELMA (Drug) $34.01
  • XPOVIO (Drug) $31.91
  • JARDIANCE (Drug) $30.74
  • AVYCAZ (Drug) $29.43
  • SPIRIVA RESPIMAT (Drug) $29.34
  • Soliris (Drug) $22.72
  • FOUNDATIONONE (Device) $17.74
  • FARXIGA (Drug) $15.68
  • ADYNOVATE (Biological) $12.96

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Waterloo